Skip Nav Destination
Article navigation
Meeting Abstracts|
September 1980
ACTIVATED CLOTTING TIME AND HEPARIN LEVELS DURING HYPOTHETIC CARDIOPULMONARY BYPASS
New York University Medical Center, 560 First Avenue, New York, New York 10016
Anesthesiology September 1980, Vol. 53, S115.
Citation
S. J. Thomas, S. N. Gitel, N. J. Starr, A. T. Culliford, S. Wessler; ACTIVATED CLOTTING TIME AND HEPARIN LEVELS DURING HYPOTHETIC CARDIOPULMONARY BYPASS. Anesthesiology 1980; 53:S115 doi: https://doi.org/10.1097/00000542-198009001-00115
Download citation file:
Citing articles via
Most Viewed
Related Articles
Is the Activated Clotting Time Dangerous?
Anesthesiology (October 2005)
Evaluation of a New Point-of-care Celite-activated Clotting Time Analyzer in Different Clinical Settings: The i-STAT Celite-activated Clotting Time Test
Anesthesiology (July 2003)
Reliability of the Heparin Management Test for Monitoring High Levels of Unfractionated Heparin: In Vitro Findings in Volunteersversus In Vivo Findings during Cardiopulmonary Bypass
Anesthesiology (June 2000)
Influence of High-dose Aprotinin on Anticoagulation, Heparin Requirement, and Celite- and Kaolin-Activated Clotting Time in Heparin-pretreated Patients Undergoing Open-Heart Surgery: A Double-blind, Placebo-controlled Study
Anesthesiology (October 1995)
Adding Examples to the ASA-Physical Status Classification Improves Correct Assignment to Patients
Anesthesiology (April 2017)